drugset / Trial / NCT00533637

Taste and Local Tolerance Study of NLA Nasal Spray in Patients With Allergic Rhinitis

NCT00533637

Phase 2 Completed 28 enrolled Biolipox AB
RandomizedCrossoverQuadruple-blindTreatment

Summary

Evaluation of NLA Nasal Spray with regard to taste perversion and local tolerance

Timeline

Start
2007-09
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetirizine Other / unclassified 10 mg/ml Intranasal

Indications